Literature DB >> 6802326

Hypophosphataemia after parathyroidectomy in chronic renal failure.

K Farrington, Z Varghese, R A Baillod, O N Fernando, J F Moorhead.   

Abstract

Out of 24 patients receiving haemodialysis who were subjected to parathyroidectomy, 13 developed hypophosphataemia; this persisted for 3-52 weeks (mean 10.6 weeks). Before operation these 13 patients had had significantly higher plasma alkaline phosphatase activities (p less than 0.01) and significantly higher values in iliac crest bone biopsy samples for active resorption surface and active formation surface (p less than 0.05 in each case) than the group who remained normophosphataemic. Significantly more of the patients who remained normophosphataemic had shown periarticular calcification in preoperative skeletal radiographs (p less than 0.001). Hypophosphataemia may result from reduced mobilisation of phosphate from bone or its increased accretion into bone, and resorption of phosphate from periarticular mineral deposits may protect against development.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6802326      PMCID: PMC1496267          DOI: 10.1136/bmj.284.6319.856

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  9 in total

1.  Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults.

Authors:  T J Hahn; B A Hendin; C R Scharp; J G Haddad
Journal:  N Engl J Med       Date:  1972-11-02       Impact factor: 91.245

2.  Plasma hydroxyproline in renal osteodystrophy.

Authors:  Z Varghese; J F Moorhead; G L Tatler; R A Baillod; M R Wills
Journal:  Proc Eur Dial Transplant Assoc       Date:  1973

Review 3.  Secondary hyperparathyroidism in chronic renal failure. The clinical spectrum in uremia, during hemodialysis, and after renal transplantation.

Authors:  S G Massry; J W Coburn; M M Popovtzer; J H Shinaberger; M H Maxwell; C R Kleeman
Journal:  Arch Intern Med       Date:  1969-10

4.  Parathyroidectomy. Treatment for secondary hyperparathyroidism and azotemic osteodystrophy.

Authors:  J J Berens; D J Potter; G M Nickas
Journal:  Arch Surg       Date:  1970-04

5.  Calcium metabolism after subtotal parathyroidectomy in chronic renal failure.

Authors:  J W Johnson; A Wachman; A I Katz; C L Hampers; D S Bernstein; R E Wilson; J P Merrill
Journal:  Trans Am Soc Artif Intern Organs       Date:  1969

6.  Physiologic studies in renal osteodystrophy treated by subtotal parathyroidectomy.

Authors:  G Gill; J Pallotta; M Kashgarian; D Kessner; R H Epstein
Journal:  Am J Med       Date:  1969-06       Impact factor: 4.965

7.  Persistent hypophosphataemia and osteomalacia in dialysis patients not on oral phosphate-binders: Response to dihydrotachysterol therapy.

Authors:  K Y Ahmed; Z Varghese; M R Wills; E Meinhard; R K Skinner; R A Baillod; J F Moorhead
Journal:  Lancet       Date:  1976-08-28       Impact factor: 79.321

8.  Persistent hypophosphatemia following parathyroidectomy in end-stage renal disease: report of three patients.

Authors:  G S Lefavour; J M Brensilver; J C Pierce; S Cortell
Journal:  Clin Nephrol       Date:  1980-01       Impact factor: 0.975

9.  Metabolic studies of renal osteodystrophy. I. Calcium, phosphorus and nitrogen metabolism in rickets, osteomalacia and hyperparathyroidism complicating chronic uremia and in the osteomalacia of the adult Fanconi syndrome.

Authors:  S W STANBURY; G A LUMB
Journal:  Medicine (Baltimore)       Date:  1962-02       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.